High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.4M
$1,406,041
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VERA
S
Vera Therapeutics, Inc.
Brenner Robert
• Officer • Chief Medical Officer
Sell to Cover
2026-02-23
$90,307
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-23 | $90,307 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-23 | $710,578 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-23 | $207,778 | S | Form 4 |
| VERA |
Vera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-02-23 | $108,276 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Skelton Laurence Matthew
• Officer • Chief Commercial Officer
Sell to Cover
2026-02-23
$66,419
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-02-23 | $66,419 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Turner William D.
• Officer • Chief Regulatory Officer
Sell to Cover
2026-02-23
$91,819
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • Chief Regulatory Officer
Sell to Cover
|
2026-02-23 | $91,819 | S | Form 4 |
|
VERA
S
Vera Therapeutics, Inc.
Young Joseph R
• Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Sell to Cover
2026-02-23
$130,864
|
||||||
| VERA |
Vera Therapeutics, Inc.
|
Officer • SVP, FINANCE, CHIEF ACCT OFFCR
Sell to Cover
|
2026-02-23 | $130,864 | S | Form 4 |